MYELOPROLIFERATIVE DISORDERS
Clinical trials for MYELOPROLIFERATIVE DISORDERS explained in plain language.
Never miss a new study
Get alerted when new MYELOPROLIFERATIVE DISORDERS trials appear
Sign up with your email to follow new studies for MYELOPROLIFERATIVE DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New transplant approach aims to cut Graft-Versus-Host disease in blood cancer patients
Disease control OngoingThis early-phase study tests a new way to do stem cell transplants for people with advanced blood cancers like leukemia. Instead of using strong drugs to prevent complications, doctors will give patients specially prepared immune cells (regulatory T-cells) along with regular dono…
Matched conditions: MYELOPROLIFERATIVE DISORDERS
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated May 17, 2026 03:09 UTC
-
New drug may reduce dangerous side effects of stem cell transplants in older patients
Disease control OngoingThis early-phase study tests whether the drug itacitinib can prevent cytokine release syndrome (a severe inflammatory reaction) and reduce the need for long-term immune-suppressing medications after a stem cell transplant. The trial involves 32 older adults (age 60+) with certain…
Matched conditions: MYELOPROLIFERATIVE DISORDERS
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
Massive study aims to uncover root causes of blood cancers
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to find the genetic causes of blood and bone marrow cancers, such as leukemia. Researchers will look for specific cell abnormalities that drive cancer growth. Up to 5,000 people with these cancers will provide samples for analysis. The goal is to develop more effe…
Matched conditions: MYELOPROLIFERATIVE DISORDERS
Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated May 17, 2026 03:10 UTC